VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,456 | +10.1% | 871,639 | +23.2% | 0.08% | +13.2% |
Q2 2023 | $21,302 | -3.9% | 707,480 | +3.3% | 0.07% | -8.1% |
Q1 2023 | $22,158 | +7.1% | 684,929 | -5.1% | 0.07% | +1.4% |
Q4 2022 | $20,680 | -99.5% | 721,543 | +321.8% | 0.07% | +356.2% |
Q3 2022 | $4,126,000 | -26.8% | 171,058 | -16.9% | 0.02% | -20.0% |
Q2 2022 | $5,636,000 | -76.6% | 205,843 | -67.2% | 0.02% | -73.7% |
Q1 2022 | $24,097,000 | -0.1% | 628,357 | -16.6% | 0.08% | +10.1% |
Q4 2021 | $24,130,000 | +2390.2% | 753,329 | +2190.9% | 0.07% | +2200.0% |
Q3 2021 | $969,000 | -91.1% | 32,884 | -89.7% | 0.00% | -90.3% |
Q2 2021 | $10,862,000 | -1.1% | 319,653 | -5.4% | 0.03% | -3.1% |
Q1 2021 | $10,982,000 | -66.4% | 337,897 | -62.8% | 0.03% | -69.2% |
Q4 2020 | $32,707,000 | -15.2% | 908,007 | -7.8% | 0.10% | -37.7% |
Q3 2020 | $38,560,000 | +4.9% | 984,678 | -1.7% | 0.17% | +0.6% |
Q2 2020 | $36,754,000 | +69.1% | 1,002,012 | +6.2% | 0.17% | +49.5% |
Q1 2020 | $21,731,000 | +58.9% | 943,206 | +101.9% | 0.11% | +98.2% |
Q4 2019 | $13,677,000 | +33.5% | 467,095 | +21.8% | 0.06% | +21.7% |
Q3 2019 | $10,242,000 | +76.0% | 383,456 | +68.4% | 0.05% | +76.9% |
Q2 2019 | $5,819,000 | -42.3% | 227,653 | -49.4% | 0.03% | -43.5% |
Q1 2019 | $10,091,000 | +74.9% | 450,095 | +64.5% | 0.05% | +58.6% |
Q4 2018 | $5,770,000 | +217.9% | 273,594 | +179.2% | 0.03% | +262.5% |
Q3 2018 | $1,815,000 | -76.4% | 97,996 | -71.5% | 0.01% | -76.5% |
Q2 2018 | $7,675,000 | -82.2% | 344,024 | -82.5% | 0.03% | -80.9% |
Q1 2018 | $43,180,000 | +740.1% | 1,964,497 | +788.2% | 0.18% | +673.9% |
Q4 2017 | $5,140,000 | -42.2% | 221,189 | -42.9% | 0.02% | -46.5% |
Q3 2017 | $8,894,000 | -34.9% | 387,359 | -37.4% | 0.04% | -25.9% |
Q2 2017 | $13,657,000 | -17.7% | 618,545 | -15.0% | 0.06% | +9.4% |
Q1 2017 | $16,592,000 | -2.5% | 727,395 | -10.6% | 0.05% | -15.9% |
Q4 2016 | $17,025,000 | +26.6% | 813,836 | +59.9% | 0.06% | +14.5% |
Q3 2016 | $13,449,000 | +762.7% | 508,847 | +804.2% | 0.06% | +685.7% |
Q2 2016 | $1,559,000 | – | 56,275 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |